BRIEF published on 11/14/2024 at 11:05, 7 days 2 hours ago Travelex Issuerco 2 Plc Reports Q3 2024 Financial Results London Stock Exchange Investor Relations Financial Announcement Travelex Issuerco 2 Plc Q3 2024 Results
PRESS RELEASE published on 11/14/2024 at 11:00, 7 days 2 hours ago Travelex Issuerco 2 Plc: 3rd Quarter Results Travelex Issuerco 2 Plc announces Q3 2024 Results. Access the results at http://www.rns-pdf.londonstockexchange.com/rns/2666M_1-2024-11-14.pdf London Stock Exchange Financial Performance Investor Relations Travelex Issuerco 2 Plc Q3 2024 Results
BRIEF published on 09/13/2024 at 09:05, 2 months 8 days ago Travelex Issuerco 2 Plc Reports Q2 2024 Results Investor Relations Stock Exchange EQS Group AG Q2 Results Travelex
PRESS RELEASE published on 09/13/2024 at 09:00, 2 months 8 days ago Results for Q2 2024 Travelex Issuerco 2 Plc announces Q2 2024 results. Access the report at http://www.rns-pdf.londonstockexchange.com/rns/0277E_1-2024-9-12.pdf London Stock Exchange Financial Report Travelex Issuerco 2 Plc Q2 2024 Results Investor Inquiries
BRIEF published on 05/15/2024 at 08:35, 6 months 6 days ago Travelex Issuerco 2 Plc Announces Q1 2024 Results London Stock Exchange Investor Relations Financial Report Q1 2024 Results Travelex
PRESS RELEASE published on 05/15/2024 at 08:30, 6 months 6 days ago 1st Quarter Results Travelex Issuerco 2 Plc announces Q1 2024 results. Find the details in the press release provided. Contact for investor queries: Victoria.Benis-Lonsdale@travelex.com London Stock Exchange Financial Report Travelex Issuerco 2 Plc Investor Queries Q1 2024 Results
PRESS RELEASE published on 02/08/2024 at 08:00, 9 months 13 days ago Results for Q4 2023 Travelex Issuerco 2 Plc announces Q4 2023 results. Access the report via the provided link. Contact Victoria.Benis-Lonsdale@travelex.com for investor queries London Stock Exchange Financial Report Travelex Issuerco 2 Plc Q4 Results Investor Queries
PRESS RELEASE published on 10/30/2023 at 14:45, 1 year ago Buy back new money notes & stapled ordinary shares
PRESS RELEASE published on 09/27/2023 at 20:20, 1 year 1 month ago Travelex Issuerco 2 Plc: Buy back new money notes and stapled shares
PRESS RELEASE published on 09/27/2023 at 11:45, 1 year 1 month ago Travelex Issuerco 2 Plc: FY2022 Audited Consolidated Financial Statements
Published on 11/21/2024 at 13:30, 28 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 28 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 58 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 58 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 58 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 23 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 43 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 38 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 13 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 13 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
